1,507
Views
2
CrossRef citations to date
0
Altmetric
Reviews

Recommendations for pediatric tuberculosis vaccination in Italy

, , , , , & show all
Pages 644-650 | Received 06 Aug 2015, Accepted 05 Oct 2015, Published online: 05 May 2016

References

  • World Health Organization. Global Tuberculosis Report 2014. Document WHO/HTM/TB/2014.08 Geneva: World Health Organization, 2014
  • Calmette A, Guerin C, Boquet A, Nègre L. La vaccination préventive contre la tuberculose par le BCG. Paris: Masson et Cie. 1927
  • Behr MA. BCG – different strains, different vaccines? Lancet Infect Dis 2002; 2:86-92; PMID:11901655; http://dx.doi.org/10.1016/S1473-3099(02)00182-2
  • Ritz N, Dutta B, Donath S, Casalaz D, Connell TG, Tebruegge M, Robins-Browne R, Hanekom WA, Britton WJ, Curtis N. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial. Am J Respir Crit Care Med 2012; 185:213-22; PMID:22071384; http://dx.doi.org/10.1164/rccm.201104-0714OC
  • Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, Rodrigues LC, Smith PG, Lipman M, Whiting PF, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 2014; 58:470-80; PMID:24336911; http://dx.doi.org/10.1093/cid/cit790
  • Ottenhoff TH, Kaufmann SH. Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog 2012; 8:e1002607; PMID:22589713; http://dx.doi.org/10.1371/journal.ppat.1002607
  • Liu J, Tran V, Leung AS, Alexander DC, Zhu B. BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy. Hum Vaccin 2009; 5:70-8; PMID:19164935; http://dx.doi.org/10.4161/hv.5.2.7210
  • Hesseling AC, Cotton MF, Fordham von Reyn C, Graham SM, Gie RP, Hussey GD. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants. Int J Tuberc Lung Dis 2008; 12:1376-79; PMID:19017445
  • Dalmia N, Ramsay AJ. Prime-boost approaches to tuberculosis vaccine development. Expert Rev Vaccines 2012; 11:1221-33; PMID:23176655; http://dx.doi.org/10.1586/erv.12.94
  • European Centre for Disease Prevention and Control: Vaccine Schedule. Available at: http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx. Accessed 3 April 2015
  • Il Programma Nazionale per le Linee Guida (PNLG). Methodological handbook – how to produce, disseminate and update clinical practice recommendations. http://www.pnlg.it/en_method. Accessed 30 December 2014
  • Scottish Intercollegiate Guidelines Netwok (SIGN). Available at http://www.sign.ac.uk/. Accessed 30 December 2014
  • Guidelines for the planning and management of NIH Consensus Development Conferences Online Bethesda (MD): National Institutes of Health, Office of the Director, Office of Medical Applications of Research; 1993. Updated October 2001
  • Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995; 96:29-35; PMID:7596718
  • Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006; 367:1173-80; PMID:16616560; http://dx.doi.org/10.1016/S0140-6736(06)68507-3
  • Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271:698-702; PMID:8309034; http://dx.doi.org/10.1001/jama.1994.03510330076038
  • Abubakar I, Pimpin L, Ariti C, Beynon R, Mangtani P, Sterne JA, Fine PE, Smith PG, Lipman M, Elliman D, et al. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis. Health Technol Assess 2013; 17:1-372; PMID:24021245; http://dx.doi.org/10.3310/hta17370
  • Pereira SM, Barreto ML, Pilger D, Cruz AA, Sant'Anna C, Hijjar MA, Ichihara MY, Santos AC, Genser B, Rodrigues LC. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial. Lancet Infect Dis 2012; 12:300-6; PMID:22071248; http://dx.doi.org/10.1016/S1473-3099(11)70285-7
  • Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, Harrison LH. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. JAMA 2004; 291:2086-91; PMID:15126436; http://dx.doi.org/10.1001/jama.291.17.2086
  • Abubakar I, Matthews T, Harmer D, Okereke E, Crawford K, Hall T, Collyns T, Smith G, Barrett A, Baugh S. Assessing the effect of foreign travel and protection by BCG vaccination on the spread of tuberculosis in a low incidence country, United Kingdom, October 2008 to December 2009. Euro Surveill 2011; 16: pii: 19826; PMID:21457684
  • Kelekçi S, Karabel M, Karabel D, Hamidi C, Hoşoğlu S, Gürkan MF, Taş MA. Bacillus Calmette-Guérin is a preventive factor in mortality of childhood tuberculous meningitis. Int J Infect Dis 2014; 21:1-4; http://dx.doi.org/10.1016/j.ijid.2013.10.001
  • Gaensbauer JT, Vandaleur M, O'Neil M, Altaf A, Ní Chróinín M. BCG protects toddlers during a tuberculosis outbreak. Arch Dis Child 2009; 94:392-3; PMID:19190006; http://dx.doi.org/10.1136/adc.2008.145755
  • Brantsaeter AB, Romanus V, Andersen PH, Heldal E. Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries. Int J Tuberc Lung Dis 2009; 13:440-5; PMID:19335948
  • Morán-Mendoza O, Marion SA, Elwood K, Patrick D, FitzGerald JM. Risk factors for developing tuberculosis: a 12-year follow-up of contacts of tuberculosis cases. Int J Tuberc Lung Dis 2010; 14:1112-9
  • Barreto ML, Cunha SS, Pereira SM, Genser B, Hijjar MA, Yury Ichihara M, de Brito SC, Dourado I, Cruz A, Santa'Ana C, et al. Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil. Int J Tuberc Lung Dis 2005; 9:1171-3; PMID:16229231
  • Eriksen J, Chow JY, Mellis V, Whipp B, Walters S, Abrahamson E, Abubakar I. Protective effect of BCG vaccination in a nursery outbreak in 2009: time to reconsider the vaccination threshold? Thorax 2010; 65:1067-71; PMID:21030395; http://dx.doi.org/10.1136/thx.2010.140186
  • Basu Roy R, Sotgiu G, Altet-Gómez N, Tsolia M, Ruga E, Velizarova S, Kampmann B. Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin? A pTB-NET collaborative study. Am J Respir Crit Care Med 2012; 186:378-84; PMID:22700862; http://dx.doi.org/10.1164/rccm.201201-0026OC
  • Eisenhut M, Paranjothy S, Abubakar I, Bracebridge S, Lilley M, Mulla R, Lack K, Chalkley D, McEvoy M. BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay. Vaccine 2009; 27:6116-20; PMID:19715782; http://dx.doi.org/10.1016/j.vaccine.2009.08.031
  • Soysal A, Millington KA, Bakir M, Dosanjh D, Aslan Y, Deeks JJ, Efe S, Staveley I, Ewer K, Lalvani A. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005; 366:1443-51; PMID:16243089; http://dx.doi.org/10.1016/S0140-6736(05)67534-4
  • Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, Rodrigues LC, Smith PG, Lipman M, Whiting PF, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 2014; 58:470-80; PMID:24336911; http://dx.doi.org/10.1093/cid/cit790
  • Weir RE, Gorak-Stolinska P, Floyd S, Lalor MK, Stenson S, Branson K, Blitz R, Ben-Smith A, Fine PE, Dockrell HM. Persistence of the immune response induced by BCG vaccination. BMC Infect Dis 2008; 8:9; PMID:18221509; http://dx.doi.org/10.1186/1471-2334-8-9
  • Rodrigues LC, Pereira SM, Cunha SS, Genser B, Ichihara MY, de Brito SC, Hijjar MA, Dourado I, Cruz AA, Sant'Anna C, et al. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet 2005; 366: 1290-5; PMID:16214599; http://dx.doi.org/10.1016/S0140-6736(05)67145-0
  • Roth AE, Benn CS, Ravn H, Rodrigues A, Lisse IM, Yazdanbakhsh M, Whittle H, Aaby P. Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau. BMJ 2010; 340:c671; PMID:20231251; http://dx.doi.org/10.1136/bmj.c671
  • Barreto ML, Pereira SM, Pilger D, Cruz AA, Cunha SS, Sant'Anna C, Ichihara MY, Genser B, Rodrigues LC. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial. Vaccine 2011; 29:4875-7; PMID:21616115; http://dx.doi.org/10.1016/j.vaccine.2011.05.023
  • Leung CC, Tam CM, Chan SL, Chan-Yeung M, Chan CK, Chang KC. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong. Int J Tuberc Lung Dis 2001; 5:717-23; PMID:11495262
  • Dantas OM, Ximenes RA, de Albuquerque Mde F, da Silva NL, Montarroyos UR, de Souza WV, Pereira TC, Campelo AR, Rodrigues LC. A case-control study of protection against tuberculosis by BCG revaccination in Recife, Brazil. Int J Tuberc Lung Dis 2006; 10:536-41; PMID:16704036
  • Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, Schaaf HS, Gie RP, Cotton MF, van Helden PD, Warren RM, et al. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 2006; 42:548-58; PMID:16421800; http://dx.doi.org/10.1086/499953
  • Bolger T, O'Connell M, Menon A, Butler K. Complications associated with the bacille Calmette-Guérin vaccination in Ireland. Arch Dis Child 2006; 91:594-7; PMID:16547086; http://dx.doi.org/10.1136/adc.2005.078972
  • Dourado I, Rios MH, Pereira SM, Cunha SS, Ichihara MY, Goes JC, Rodrigues LC, Bierrenbach AL, Barreto ML. Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren. Int J Tuberc Lung Dis 2003; 7:399-402; PMID:12729348
  • Deeks SL, Clark M, Scheifele DW, Law BJ, Dawar M, Ahmadipour N, Walop W, Ellis CE, King A. Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada. Pediatr Infect Dis J 2005; 24:538-41; PMID:15933565; http://dx.doi.org/10.1097/01.inf.0000164769.22033.2c
  • Dommergues MA, de La Rocque F, Guy C, Lécuyer A, Jacquet A, Guérin N, Fagot JP, Boucherat M, d'Athis P, Cohen R. Local and regional adverse reactions to BCG-SSI vaccination: a 12-month cohort follow-up study. Vaccine 2009; 27:6967-73; PMID:19800440; http://dx.doi.org/10.1016/j.vaccine.2009.09.073
  • Turnbull FM, McIntyre PB, Achat HM, Wang H, Stapledon R, Gold M, Burgess MA. National study of adverse reactions after vaccination with bacilli Calmette-Guérin. Clin Infect Dis 2002; 34:447-53; PMID:11797170; http://dx.doi.org/10.1086/338462
  • Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PE, Godfrey-Faussett P, Beyers N. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 2007; 25:14-8; PMID:16959383; http://dx.doi.org/10.1016/j.vaccine.2006.07.020
  • Tissot F, Zanetti G, Francioli P, Zellweger JP, Zysset F. Influence of bacilli Calmette-Guérin vaccination on size of tuberculin skin test reaction: to what size? Clin Infect Dis 2005; 40:211-7; PMID:15655737; http://dx.doi.org/10.1086/426434
  • Menzies D. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us? Clin Infect Dis 2000; 31:S71-4; PMID:11010826; http://dx.doi.org/10.1086/314075
  • Tsolia MN, Mavrikou M, Critselis E, Papadopoulos NG, Makrinioti H, Spyridis NP, Metsou F, Tsagaraki M, Koulouri M, Kafetzis DA. Whole blood interferon-γ release assay is a useful tool for the diagnosis of tuberculosis infection particularly among Bacille Calmette Guèrin-vaccinated children. Pediatr Infect Dis J 2010; 29:1137-40; PMID:20616761; http://dx.doi.org/10.1097/INF.0b013e3181ebfe8a
  • Jacobs S, Warman A, Richardson R, Yacoub W, Lau A, Whittaker D, Cockburn S, Verma G, Boffa J, Tyrrell G, et al. The tuberculin skin test is unreliable in school children BCG-vaccinated in infancy and at low risk of tuberculosis infection. Pediatr Infect Dis J 2011; 30:754-8; PMID:21487326; http://dx.doi.org/10.1097/INF.0b013e31821b8f54
  • Piñeiro R, Mellado MJ, Cilleruelo MJ, García-Ascaso M, Medina-Claros A, García-Hortelano M. Tuberculin skin test in bacille Calmette-Guérin-vaccinated children: how should we interpret the results? Eur J Pediatr 2012; 171:1625-32; http://dx.doi.org/10.1007/s00431-012-1783-8
  • Boyzaykut A, Ipek IO, Ozkars MY, Seren LP, Atay E, Atay Z. Effect of BCG vaccine on tuberculin skin tests in 1-6-year-old children. Acta Paediatr 2002; 91:235-8; PMID:11952015; http://dx.doi.org/10.1111/j.1651-2227.2002.tb01701.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.